Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Progesterone (excl. Dafo. Wka), Atc G03da04 For The Period 02/01/26 - 01/31/28 (plus V. Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Desvenlafaxine, Atc N06ax23 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Brimonidine + Timolol, Atc S01ed69 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Betahistine, Atc N07ca01 For The Period 01.02.26 - 31.01.28 (plus Extension Option 1x12 Months) Betahistine 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Desvenlafaxin For The Period 01.02.2026 - 31.01.2028 (plus Extension Option 1x12 Months). Desvenlafaxin 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Progesterone For The Period 01.02.26 - 31.01.28 (plus Option For 1x12 Months). Progesterone 2026-06-12
Sweden Sustainable Certified Chenin Blanc Coastal Region Bag-in-box 3000 Ml Or Bulk (a) - 561-20 2026-06-12
Germany Openhouse Biological Discount Contracts 202534 Eculizumab 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Prednisolone, Atc S01ba04 For The Period 01.02.2026 - 31.01.2028 (plus Extension Option 1x12 Months). Prednisolone 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Brimonidine For The Period 01.02.26 - 31.01.28 (plus Option For 1x12 Months). Brimonidine 2026-06-12
Whats app